Были некоторые проблемы с проверкой (отсутствующие и дополнительные теги tr и td и т. д.) в вашем коде, и CSS определенно нужно запускать через встроенный код (например, Mailchimps — но убедитесь, что ваши медиа-запросы выполняются и не удаляются во встроенном файле.) перед использованием, но ниже СЛЕДУЕТ решить вашу проблему:
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta name="viewport" content="width=device-width; initial-scale=1.0; maximum-scale=1.0; minimum-scale=1.0; user-scalable=0;" />
<meta name="SKYPE_TOOLBAR" content="SKYPE_TOOLBAR_PARSER_COMPATIBLE"/>
<title>Oncology</title>
<style type="text/css">
#outlook a {
padding:0;
}
html,body{font-family:Arial, Helvetica, sans-serif; font-weight:normal; text-transform:none; margin:0px; padding:0px;}
.clr { margin:0; padding:0; clear:both;}
.container{ margin:0px auto; width:600px; padding:0px 0px;}
.header{
margin:0px 0px; padding:15px 50px 0px; width:500; display:block;
/* Safari 4-5, Chrome 1-9 */
background: -webkit-gradient(linear, 0% 0%, 0% 100%, from(#dcf6fc), to(#fff));
/* Safari 5.1, Chrome 10+ */
background: -webkit-linear-gradient(top, #dcf6fc, #fff);
/* Firefox 3.6+ */
background: -moz-linear-gradient(top, #dcf6fc, #fff);
/* IE 10 */
background: -ms-linear-gradient(top, #dcf6fc, #fff);
/* Opera 11.10+ */
background: -o-linear-gradient(top, #dcf6fc, #fff);
}
.logo{ margin:0px; padding:10px 0px 0px 0px; width:502px; }
.logo img{ margin:0px; padding:0px; width:auto; height:auto; display: block;}
.icons{ margin:0px; padding:0px; width:96px; text-align:center }
.icons h6{ margin:0px 0px 0px 0px; padding:10px 0px 30px 0px ; color:#272626; font-size:13px; font-weight:400; display:block;}
.info{ margin:0px 0px 0px 0px; padding:25px 0px; text-align:center;}
.info img{ margin:0px; padding: 0 12px; width:auto; height:auto; max-width:100%; vertical-align:middle;}
.info a{ margin:0px; padding:0px; color:#7e3553; font-size:15px; font-weight:normal; text-decoration:none; display:inline-block;}
.banner{ margin:0px; padding:0px 50px;}
.banner img{ margin:0px 0px 0px; padding:0px; display: block; width: 100%;}
.body_left{ margin:0px; padding:0px 15px 0px 55px; width:64%;}
.body_right{ margin:0px; padding:0px 50px 0px 0px; width:33%; }
.subscribe{ margin:0px 0px 40px 0px; padding:0px; text-align:center; display:block;}
.subscribe a{ margin:0px; padding:6px 15px; color:#fff; font-size:12px; font-weight:400; display:inline-block; text-decoration:none; border-radius:5px; text-align:center;
border-bottom:1px solid #000;
/* IE10 Consumer Preview */
background-image: -ms-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Mozilla Firefox */
background-image: -moz-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Opera */
background-image: -o-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Webkit (Safari/Chrome 10) */
background-image: -webkit-gradient(linear, left top, left bottom, color-stop(0, #017c9c), color-stop(1, #4eaac2));
/* Webkit (Chrome 11+) */
background-image: -webkit-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* W3C Markup, IE10 Release Preview */
background-image: linear-gradient(to bottom, #017c9c 0%, #4eaac2 100%);
}
.sidebox1{ margin:0px 0px 35px; padding:0px; display:block; text-align:center;}
.sidebox1 img{ margin:0px; padding:0px; width:auto; height:auto; max-width:100%;}
.sidebox2{ margin:0px; padding:0px; display:block; text-align:center;}
.sidebox2 img{ margin:0px; padding:0px; width:auto; height:auto; max-width:100%;}
.news_read{ margin:0px 0px 5px 0px; padding:0px; border-bottom:1px solid #d2d3d2; display:block;}
.news_read strong{ margin:0px; padding:2px 6px; color:#fff; font-size:13px; font-weight:400; text-decoration:none; display:inline-block; background:#017c9c;}
.news_box{ margin:0px 0px 5px 0px; padding:0px; border-bottom:2px dotted #cccccc;}
.news_box h6{ margin:0px; padding:0px; color:#272626; font-size:13px; font-weight:400; line-height:16px; display:block;}
.news_box h6 a{ margin:0px 0px 8px 0px; padding:0px; color:#272626; font-size:13px; font-weight:400; line-height:16px; display:block; text-decoration:none;}
.news_box h6 a:hover{ color:#017c9c;}
.news_box label{ margin:0px; padding:0px; color:#616364; font-size:10px; font-weight:400; display:block;}
.news_box label span{ margin:0px; padding:0px; color:#7e3553; font-size:10px; font-weight:400; font-style:italic;}
.news_box p{ margin:0px; padding:0px 0px 5px 0px; color:#808080; font-size:11px; font-weight:400; line-height:14px;}
.news_box p a{ margin:0px; padding:0px; color:#0082a2; font-size:10px; font-weight:400; text-decoration:none;}
.news_box p a:hover{ color:#272626;}
.social_link{ margin:0px; padding:0px;}
.social_link img{ margin:0px 0px 6px 0px; padding:0px; width:auto; height:auto; max-width:100%;}
.footer{ margin:0px auto; padding:0px 50px; text-align:center; width:100%; display:block;}
.footer p{ margin:0px; padding:0px 0px 10px 0px; color:#363333; font-size:11px; font-weight:400; line-height:18px;}
.site_link{ margin:0px 0px 8px 0px; padding:0px; text-align:center;}
.site_link a{ margin:0px 0px 5px 0px; padding:10px 35px; color:#fff; font-size:15px; font-weight:400; display:inline-block; text-decoration:none; border-radius:3px;
border-bottom:1px solid #000;
/* IE10 Consumer Preview */
background-image: -ms-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Mozilla Firefox */
background-image: -moz-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Opera */
background-image: -o-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* Webkit (Safari/Chrome 10) */
background-image: -webkit-gradient(linear, left top, left bottom, color-stop(0, #017c9c), color-stop(1, #4eaac2));
/* Webkit (Chrome 11+) */
background-image: -webkit-linear-gradient(top, #017c9c 0%, #4eaac2 100%);
/* W3C Markup, IE10 Release Preview */
background-image: linear-gradient(to bottom, #017c9c 0%, #4eaac2 100%);
}
.footer span{ margin:0px 0px 5px 0px; padding:0px; color:#2eb5d9; font-size:11px; display:block;}
.footer span a{ margin:0px; padding:0px; color:#2eb5d9; font-size:11px; display:inline-block; text-decoration:none;}
.footer label{ margin:0px 0px 0px 0px; padding:0px; color:#999999; font-size:11px; display:block;}
.footer label a{ margin:0px; padding:0px; color:#999999; font-size:11px; display:inline-block;}
.footer label br{ display:none;}
.footerbottom{margin:0px auto; padding:8px 50px 30px; text-align:center;width:100%;
/* Safari 4-5, Chrome 1-9 */
background: -webkit-gradient(linear, 0% 0%, 0% 100%, from(#f2fcfe), to(#c9f1fb));
/* Safari 5.1, Chrome 10+ */
background: -webkit-linear-gradient(top, #f2fcfe, #c9f1fb);
/* Firefox 3.6+ */
background: -moz-linear-gradient(top, #f2fcfe, #c9f1fb);
/* IE 10 */
background: -ms-linear-gradient(top, #f2fcfe, #c9f1fb);
/* Opera 11.10+ */
background: -o-linear-gradient(top, #f2fcfe, #c9f1fb);
}
.footer_logo{ margin:0px 0px 10px 0px; padding:0px; text-align:center; }
.footer_logo img{ margin:0px 0px 10px 0px; padding:0px; width:auto; height:auto; max-width:100%;}
.copywrite{ margin:0px; padding:0px; text-align:center;}
.copywrite span{ margin:0px 0px 5px 0px; padding:0px; color:#017c9c; font-size:11px; display:block;}
.copywrite label{ margin:0px 0px 5px 0px; padding:0px; color:#363333; font-size:11px; display:block;}
/* Mobile Landscape Size to Tablet Portrait (devices and browsers) */
@media only screen and (min-width: 480px) and (max-width: 600px) {
.container{ margin:0px auto; width:80%; padding:0px; display:block; }
.header{ padding:15px 0px 0px 0px;}
.info{padding:6px 0px;}
.logo {display:block; width:100%; text-align:center;}
.logo img{ width:80%;}
.banner{ padding:0px;}
.banner img{ width:100%}
.body_left{ padding: 0 15px 0 0;}
.body_right { padding: 0;}
.footer{ padding:0px;}
.footer p br{ display:none !important; display:none; width:0; height:0; line-height:0; overflow:hidden; visibility:hidden; mso-hide:all;}
.footerbottom{padding: 8px 0 10px;}
}
@media only screen and (max-width: 480px) {
.container{ margin:0px auto; width:80%; padding:0px; display:block; }
.header{ padding:5px 0px 0px 0px;}
.info{padding:0px;}
.info img{padding:0px 5px;}
.info a{ font-size:12px;}
.logo {display:block; width:100%; text-align:center;}
.logo img{ width:100%;}
.icons{ margin:0px auto; width:96px; display:block;}
.icons h6{ padding:10px 0px 15px 0px;}
.banner{ padding:0px;}
.banner img{ width:100%}
.body_left{padding:0px; width:100%; display:block;}
.body_right{ padding: 0; width:100%; display:block;}
.subscribe{ margin:0px; padding:10px 0px;}
.sidebox1{ margin:0px; padding:0px 0px 10px; display:none !important; width:0 !important; height:0 !important; line-height:0 !important; overflow:hidden !important; visibility:hidden !important;}
.sidebox2{ margin:0px; padding:0px 0px 5px 0px; display:none !important; width:0 !important; height:0 !important; line-height:0 !important; overflow:hidden !important; visibility:hidden !important;}
.footer{ padding:0px;}
.footerbottom{padding: 8px 0 10px;}
}
</style>
</head>
<body style="margin:0px; padding:0px;">
<table align="center" class="container">
<tr>
<td valign="top" class="header">
<table border="0" cellspacing="0" cellpadding="0" >
<tr>
<td class="logo"><a href="#"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/logo.png" ></a></td>
<td class="icons" valign="top">
<h6>May 18, 2015</h6>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="social">
<tr>
<td><a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb-icon.png"></a></td>
<td><a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw-icon.png"></a></td>
<td><a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in-icon.png"></a></td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td valign="top" class="info">
<a href="#">Online First</a><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/li-div.png"><a href="#">FDA Updates</a><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/li-div.png"><a href="#">Clinical Resource Center</a>
</td>
</tr>
<tr>
<td valign="top" class="banner"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/banner.png"></td>
</tr>
<tr>
<td valign="top" style="padding-top:20px;">
<table width="100%" border="0" cellspacing="0" cellpadding="0" >
<tr>
<td class="body_left" valign="top">
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td class="news_read"><strong>Top News</strong></td>
</tr>
<tr>
<td >
<h6><a href="#">Two FDA Advisory Committees Recommend Approval of Talimogene for Metastatic Melanoma</a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>Peggy Eastman</span></label></td>
</tr>
<tr>
<td>
<p>In a joint meeting, two advisory committees to the Food and Drug Administration recommended approval of the biologic agent talimogene laherparepvec (T-VEC) for injectable regionally or distantly metastatic melanoma. <a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td >
<h6><a href="#">Two New Drugs Promising in Attack of Attractive Targets in CTCL </a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>Mark Fuerst</span></label></td>
</tr>
<tr>
<td>
<p>Drugs now in development show promise in attacking two attractive targets of cutaneous T-cell lymphoma (CTCL). <a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td >
<h6><a href="#">SCLC: Evidence that Maintenance Sunitinib Can Extend Progression-Free Survival in Patients with Extensive Disease</a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>Kurt Samson</span></label></td>
</tr>
<tr>
<td>
<p>The tyrosine kinase inhibitor sunitinib appears to offer a small improvement in progression-free survival in patients receiving chemotherapy for extensive-stage small-cell lung cancer (ES-SCLC). <a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td class="news_read"><strong>Must Read</strong></td>
</tr>
<tr>
<td >
<h6><a href="#">Experts Say Here's How to Improve Mammography Interpretation...</a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>Peggy Eastman</span></label></td>
</tr>
<tr>
<td>
<p>Speakers agreed that while the technical quality of mammography has improved since the national Mammography Quality Standards Act (MQSA) of 1992, the interpretation of mammograms remains variable, which limits the detection of early breast cancer. <a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td >
<h6><a href="#">Genome Editing-and Future of the human Species</a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>George W. Sledge, Jr., MD</span></label></td>
</tr>
<tr>
<td>
<p>If you want to see what athe future holds for us, tel me suggest two recent articles...<a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="news_box" >
<tr>
<td >
<h6><a href="#">What ASCO's Payment Reform Idea Means to YOU</a></h6>
</td>
</tr>
<tr>
<td ><label>by <span>Lola Butcher</span></label></td>
</tr>
<tr>
<td>
<p>2015 is trying to go down in history as the year of payment reform for cancer care, and ASCOisn't going to miss out of the fun... <a href="#">Read More.</a></p>
</td>
</tr>
<tr>
<td class="social_link">
<a href="https://www.facebook.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/fb.png"></a>
<a href="https://www.twitter.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/tw.png"></a>
<a href="https://www.linkedin.com" target="_blank"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/in.png"></a>
</td>
</tr>
</table>
</td>
<td class="body_right" valign="top">
<table width="100%">
<tr>
<td class="subscribe"><a href="#">Subscribe to this enews</a></td>
</tr>
<tr>
<td class="sidebox1"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/sidebar-img1.jpg"></td>
</tr>
<tr>
<td class="sidebox2"> <img src="http://www.webdesignagencynewyork.com/dev/oncology/images/sidebar-img2.jpg" ></td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td>
<table border="0" cellspacing="0" cellpadding="0" class="footer">
<tr >
<td >
<p>Keep receiving Oncology Times eNews by adding [email protected] to your address book.<br>
Oncology Times respects your privacy and will not share your information with other companies or organizations without your permission. View our Privacy Policy.</p>
</td>
</tr>
<tr>
<td class="site_link"><a href="www.oncology-times.com" target="_blank">www.oncology-times.com</a></td>
</tr>
<tr>
<td><span><a href="mailto:[email protected]">[email protected]</a></span></td>
</tr>
<tr>
<td><label>If you do not wish to recieve<br> the Oncology Times enews please <a href="#">unsubscribe</a>.</label></td>
</tr>
</table>
</td>
</tr>
<tr>
<td >
<table class="footerbottom" border="0" cellspacing="0" cellpadding="0">
<tr >
<td class="footer_logo" width="100%" ><a href="#"><img src="http://www.webdesignagencynewyork.com/dev/oncology/images/footer-logo.png" ></a></td>
</tr>
<tr >
<td class="copywrite" ><span>333 Seventh Ave., 19th Fl., New York, NY 10001</span>
<label>Copyright ©2015 All Rights Reserved.</label></td>
</tr>
</table>
</td>
</tr>
</table>
</body>
</html>
person
Gortonington
schedule
09.07.2015
!important, а неimportant!. - person esqew schedule 08.07.2015